These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38868302)

  • 41. Retrospective Multicenter Evaluation of the VirClia Galactomannan Antigen Assay for the Diagnosis of Pulmonary Aspergillosis with Bronchoalveolar Lavage Fluid Samples from Patients with Hematological Disease.
    Buil JB; Huygens S; Dunbar A; Schauwvlieghe A; Reynders M; Langerak D; van Dijk K; Bruns A; Haas PJ; Postma DF; Biemond B; Delma FZ; de Kort E; Melchers WJG; Verweij PE; Rijnders B
    J Clin Microbiol; 2023 May; 61(5):e0004423. PubMed ID: 37097150
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of invasive fungal diseases in immunocompromised patients by combining an Aspergillus specific PCR with a multifungal DNA-microarray from primary clinical samples.
    Boch T; Reinwald M; Postina P; Cornely OA; Vehreschild JJ; Heußel CP; Heinz WJ; Hoenigl M; Eigl S; Lehrnbecher T; Hahn J; Claus B; Lauten M; Egerer G; Müller MC; Will S; Merker N; Hofmann WK; Buchheidt D; Spiess B
    Mycoses; 2015 Dec; 58(12):735-45. PubMed ID: 26497302
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rapid detection of fungal pathogens in bronchoalveolar lavage samples using panfungal PCR combined with high resolution melting analysis.
    Bezdicek M; Lengerova M; Ricna D; Weinbergerova B; Kocmanova I; Volfova P; Drgona L; Poczova M; Mayer J; Racil Z
    Med Mycol; 2016 Oct; 54(7):714-24. PubMed ID: 27161789
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Use of Aspergillus fumigatus real-time PCR in bronchoalveolar lavage samples (BAL) for diagnosis of invasive aspergillosis, including azole-resistant cases, in high risk haematology patients: the need for a combined use with galactomannan.
    Mikulska M; Furfaro E; De Carolis E; Drago E; Pulzato I; Borghesi ML; Zappulo E; Raiola AM; Grazia CD; Del Bono V; Cittadini G; Angelucci E; Sanguinetti M; Viscoli C
    Med Mycol; 2019 Nov; 57(8):987-996. PubMed ID: 30753590
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Accuracy of Pneumocystis jirovecii Plasma Cell-Free DNA PCR for Noninvasive Diagnosis of Pneumocystis Pneumonia.
    Moreno A; Epstein D; Budvytiene I; Banaei N
    J Clin Microbiol; 2022 May; 60(5):e0010122. PubMed ID: 35387472
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Performance of the AsperGenius® PCR assay for detecting azole resistant Aspergillus fumigatus in BAL fluids from allogeneic HSCT recipients: A prospective cohort study from Essen, West Germany.
    Pelzer BW; Seufert R; Koldehoff M; Liebregts T; Schmidt D; Buer J; Rath PM; Steinmann J
    Med Mycol; 2020 Feb; 58(2):268-271. PubMed ID: 31111913
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metagenomic Next-Generation Sequencing of Plasma for Diagnosis of COVID-19-Associated Pulmonary Aspergillosis.
    Hoenigl M; Egger M; Price J; Krause R; Prattes J; White PL
    J Clin Microbiol; 2023 Mar; 61(3):e0185922. PubMed ID: 36809121
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Direct comparison of galactomannan performance in concurrent serum and bronchoalveolar lavage samples in immunocompromised patients at risk for invasive pulmonary aspergillosis.
    Boch T; Buchheidt D; Spiess B; Miethke T; Hofmann WK; Reinwald M
    Mycoses; 2016 Feb; 59(2):80-5. PubMed ID: 26627577
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Diagnosis of invasive pulmonary aspergillosis in children with bronchoalveolar lavage galactomannan.
    de Mol M; de Jongste JC; van Westreenen M; Merkus PJ; de Vries AH; Hop WC; Warris A; Janssens HM
    Pediatr Pulmonol; 2013 Aug; 48(8):789-96. PubMed ID: 22949309
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Aspergillus galactomannan antigen assay in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.
    Park SY; Lee SO; Choi SH; Sung H; Kim MN; Choi CM; Hong SB; Oh YM; Shim TS; Koh Y; Kim YS; Woo JH; Kim SH
    J Infect; 2010 Dec; 61(6):492-8. PubMed ID: 20833201
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of a novel Aspergillus lateral-flow device and the Platelia® galactomannan assay for the diagnosis of invasive aspergillosis following haematopoietic stem cell transplantation.
    Held J; Schmidt T; Thornton CR; Kotter E; Bertz H
    Infection; 2013 Dec; 41(6):1163-9. PubMed ID: 23661288
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid.
    Musher B; Fredricks D; Leisenring W; Balajee SA; Smith C; Marr KA
    J Clin Microbiol; 2004 Dec; 42(12):5517-22. PubMed ID: 15583275
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comprehensive assessment of the prolonged febrile neutropenia evaluation in pediatric oncology patients.
    Whitehurst DA; Friedman DL; Zhao Z; Sarma A; Snyder E; Dulek DE; Banerjee R; Kitko CL; Esbenshade AJ
    Pediatr Blood Cancer; 2024 Mar; 71(3):e30818. PubMed ID: 38110594
    [TBL] [Abstract][Full Text] [Related]  

  • 54.
    Imbert S; Meyer I; Palous M; Brossas JY; Uzunov M; Touafek F; Gay F; Trosini-Desert V; Fekkar A
    Front Microbiol; 2018; 9():1877. PubMed ID: 30154779
    [No Abstract]   [Full Text] [Related]  

  • 55. Clinical evaluation of two different (1,3)-ß-d-glucan assays for diagnosis of invasive fungal diseases: A retrospective cohort study.
    Zubkowicz M; Held J; Baier M; Pletz MW; Kesselmeier M; Hagel S; Bahrs C
    Mycoses; 2021 Feb; 64(2):212-219. PubMed ID: 33156525
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1→ 3)-β-d-glucan chromogenic assay in serum samples.
    Acosta J; Catalan M; del Palacio-Peréz-Medel A; Lora D; Montejo JC; Cuetara MS; Moragues MD; Ponton J; del Palacio A
    Clin Microbiol Infect; 2011 Jul; 17(7):1053-60. PubMed ID: 20825441
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cell-free DNA next-generation sequencing successfully detects infectious pathogens in pediatric oncology and hematopoietic stem cell transplant patients at risk for invasive fungal disease.
    Armstrong AE; Rossoff J; Hollemon D; Hong DK; Muller WJ; Chaudhury S
    Pediatr Blood Cancer; 2019 Jul; 66(7):e27734. PubMed ID: 30941906
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Diagnostic accuracy of PCR alone compared to galactomannan in bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis: a systematic review.
    Avni T; Levy I; Sprecher H; Yahav D; Leibovici L; Paul M
    J Clin Microbiol; 2012 Nov; 50(11):3652-8. PubMed ID: 22952268
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Comparison of the Results of Galactomannan and Beta Glucan Antigen Tests in the Suspicion of Invasive Pulmonary Aspergillosis].
    Çuhadar T; Kalkancı A; Tunçcan Güzel Ö; Yeğin ZA; Özkurt ZN; Köktürk N; Yağcı M
    Mikrobiyol Bul; 2023 Apr; 57(2):274-282. PubMed ID: 37067211
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Serum Aspergillus galactomannan lateral flow assay for the diagnosis of invasive aspergillosis: A single-centre study.
    Serin I; Dogu MH
    Mycoses; 2021 Jun; 64(6):678-683. PubMed ID: 33683715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.